Skip to main content

Weiss Patrick's Form 4 filing

Twist Bioscience Corp (TWST) · filed Sep 17, 2021

Accession no.
0001214659-21-009618
Filed
Sep 17, 2021
Trade date
Sep 15, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $551.9K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Weiss PatrickCIK 0001755793Officer (Chief Operating Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 15, 2021Common StockMOption exerciseAcquired+2,104$8.82+$18,557.2851,336Direct
Sep 15, 2021Common StockMOption exerciseAcquired+1,974$26.66+$52,626.8453,310Direct
Sep 15, 2021Common StockMOption exerciseAcquired+827$25.02+$20,691.5454,137Direct
Sep 15, 2021Common StockSSaleDisposed−4,905$112.52−$551,910.649,232Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 15, 2021Common StockMOption exerciseDisposed−2,104$0.00$02,105Direct
Sep 15, 2021Common StockMOption exerciseDisposed−1,974$0.00$053,298Direct
Sep 15, 2021Common StockMOption exerciseDisposed−827$0.00$022,340Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)